Publication Type : Journal Article
Publisher : International Immunopharmacology
Source : International Immunopharmacology, 2022;104:108452. doi:10.1016/j.intimp.2021.108452
Url : https://www.sciencedirect.com/science/article/abs/pii/S1567576921010882
Campus : Kochi
School : School of Medicine
Department : C. V. T. S.
Year : 2022
Abstract : Sepsis is a serious and menacing organ dysfunction that occur due to dysregulated response of the host towards the infection. This organ dysfunction may lead to sepsis with intense cellular, metabolic and circulatory dysregulation, multiple organ failure and high mortality. Lymphopenia is observed in two-third of sepsis patients and a significant depletion of lymphocytes occurs in non-survivors compared to sepsis survivors. Myeloid derived suppressor cells (MDSCs) gave new insights into sepsis-associated lymphopenia. If MDSC expansion and its tissue-infiltration persist, it can induce significant pathophysiology including lymphopenia, host immunosuppression and immune-paralysis that contributes to worsened patient outcomes. This review focuses on MDSCs and its subsets, the role of MDSCs in infection, sepsis and septic shock.
Cite this Research Publication : M. Malavika, S. Sanju, M.R. Poorna, Veeraraghavan Vishnu Priya, Neeraj Sidharthan, Praveen Varma, Ullas Mony, Role of myeloid derived suppressor cells in sepsis, International Immunopharmacology, 2022;104:108452. doi:10.1016/j.intimp.2021.108452